Surgical treatment options currently include hysteroscopic myomectomy, abdominal myomectomy, laparoscopic myomectomy, and endometrial ablation. Many women with fibroids can be treated with these ...
Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...
Please provide your email address to receive an email when new articles are posted on . Reintervention rates were higher for hysteroscopic myomectomy, uterine artery embolization and endometrial ...
BERKELEY, Calif.--(BUSINESS WIRE)--Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that the first ...
“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...
Hologic, one of the few companies to emerge from the pandemic stronger than it was before, has scored regulatory approvals in Canada and Europe for an updated version of its NovaSure V5 endometrial ...
A recent study has found that 29% of people in Ontario who undergo endometrial ablation will have a subsequent hysterectomy to remove the entire uterus within 15 years. Among women who have been ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback